Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Kardigan, Inc. is a clinical-stage precision therapeutics company. It is developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. Its pipeline of products includes Danicamtiv, Ataciguat and Tonlamarsen. Danicamtiv is an investigational oral cardiac atrial and ventricular myosin activator for the treatment of genetic dilated cardiomyopathy caused by pathogenic variants in myosin heavy chain 7 (MYH7) and titin, the common sarcomeric gene variants. Ataciguat is an investigational oral, once-daily soluble guanylate cyclase activator aimed at slowing the progression of calcific aortic valve stenosis in patients with moderate diseases. Tonlamarsen is an investigational liver-directed antisense oligonucleotide administered once-monthly via subcutaneous injection, targeting hepatic angiotensinogen for the management of blood pressure in acute severe hypertension post-hospitalization. Prolaio is a clinical intelligence platform.
Find out what a historical investment in Kardigan would be worth today using our KARD stock calculator.
Buying KARD shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Kardigan in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in KARD
What is the ticker symbol of Kardigan?
The ticker symbol for Kardigan is KARD.
How much is one share of KARD?
One share of KARD is valued at $12.52 as of 20 November 2026.
What is the market capitalisation of Kardigan KARD?
As of 20 November 2026 Kardigan has a market cap of $1.15B.
What is the 52-week high for Kardigan stock?
The Kardigan 52-week high stock price is $27.00.
What is the 52-week low for Kardigan stock?
The Kardigan 52-week low stock price is $12.23.
Can I buy KARD shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy KARD shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KARD on Stake
Buy KARD from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of KARD from only US$10 with fractional shares